Ellen O'Connor Vos - 16 Aug 2022 Form 4/A - Amendment Insider Report for OptimizeRx Corp (OPRX)

Role: Director
Signature: /s/ Marion Odence-Ford, by Power of Attorney
Issuer symbol: OPRX
Transactions as of: 16 Aug 2022
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 19 Aug 2022, 16:45:18 UTC
Date Of Original Report: 17 Aug 2022
Previous filing: 08 Aug 2022
Next filing: 30 Sep 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	OPRX	Common Stock						33,390	16 Aug 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This amendment is being filed to correct the amount of securities beneficially owned following reported transaction which were understated by 32,890 shares.

Remarks:

The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.